Circulating Tumor Cells and Cancer Stem Cells Technologies - Global Strategic Business Report - KNOE 8 News; KNOE-TV; KNOE.com |

Circulating Tumor Cells and Cancer Stem Cells Technologies - Global Strategic Business Report

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, May 16, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/6mvft5/circulating_tumor) has announced the addition of the "Circulating Tumor Cells and Cancer Stem Cells Technologies - Global Strategic Business Report" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

This report analyzes the worldwide markets for Circulating Tumor Cells and Cancer Stem Cells Technologies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.

Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 66 companies including many key and niche players such as:

  • Alchemia Limited
  • Amgen Inc.
  • Exelixis, Inc.
  • Formula Pharmaceuticals
  • GlaxoSmithKline PLC

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY
1. CIRCULATING TUMOR CELLS (CTCS) GLOBAL MARKET OVERVIEW
2. MARKET TRENDS AND DRIVERS
3. CANCER STEM CELLS GLOBAL MARKET OVERVIEW
4. CTC AND CSC RESEARCH FINDINGS & BREAKTHROUGHS
5. MEDICAL DIAGNOSTICS MARKET A CONCEPTUAL OVERVIEW
6. CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS ENRICHMENT, IDENTIFICATION AND CHARACTERIZATION METHODS
7. CANCER STEM CELLS (CSCS) BIOLOGY, ISOLATION, CSC SURFACE MARKERS, AND SIGNALING PATHWAYS
8. PRODUCT LAUNCHES AND INTRODUCTIONS
9. RECENT INDUSTRY ACTIVITY
10. FOCUS ON SELECT MAJOR PLAYERS IN CTC DIAGNOSTICS
11. SELECT MARKET PARTICIPANTS IN THE CANCER STEM CELLS (CSCS) SPACE
12. GLOBAL MARKET PERSPECTIVE

III. MARKET
1. THE UNITED STATES
2. CANADA
3. JAPAN
4. EUROPE
5. ASIA-PACIFIC
6. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 66 (including Divisions/Subsidiaries 67)

  • The United States (46)
  • Canada (3)
  • Japan (2)
  • Europe (9)
  • France (3)
  • Germany (2)
  • The United Kingdom (1)
  • Rest of Europe (3)
  • Asia-Pacific (Excluding Japan) (4)
  • Middle East (3)

For more information visit http://www.researchandmarkets.com/research/6mvft5/circulating_tumor

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KNOE. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.